Hastings Innovation Award for Interstitial Lung Disease Award
The Hastings Innovation Award for Interstitial Lung Disease supports early career researchers advancing innovative science on interstitial lung diseases, funded by the American Lung Association.
Funder: American Lung Association
Due Dates: September 18, 2026: Letter of Intent deadline (if applicable) | December 1, 2026: Full application submission deadline
Funding Amounts: $75,000/year for up to two years (maximum $150,000 total); no indirect costs allowed
Summary: Supports outstanding early career investigators advancing research and innovation in interstitial lung disease.
Key Information: Applicants must have held an NIH K- or R-type award in the past 5 years and cannot have served as PI on 3+ large federal grants.
Description
The Hastings Innovation Award for Interstitial Lung Disease, offered by the American Lung Association, is designed to support highly promising early career investigators who have demonstrated excellence and productivity in lung disease research. The award aims to drive innovation and advance the understanding of interstitial lung diseases by investing in pioneering scientific minds. Projects should be basic, clinical, or translational research with the potential to uncover new knowledge and improve the lives of those affected by lung disease.
